Bifunctional Molecules: A Diverse New Modality That Unlocks New Target Classes
JN4025 Wuxi PROTAC Article Design Final_HR_no_crops
Related Content
Looking for a solution to accelerate your drug discovery processes? WuXi AppTec's integrated Direct-to-Biology (D2B) platform is a cost-effective and...
VIEW RESOURCEHigh-throughput screening (HTS) remains a foundational technology in early drug discovery, responsible for identifying approximately one-third of today’s clinical candidates....
VIEW RESOURCE